Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Inventiva
  6. News
  7. Summary
    IVA   FR0013233012

INVENTIVA

(IVA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inventiva S A : A statement of beneficial ownership of common stock by certain persons

02/09/2021 | 06:15am EDT

This format is in the process of being created from the filing. Please check back shortly.

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Inventiva SA published this content on 09 February 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 February 2021 11:14:07 UTC.


© Publicnow 2021
All news about INVENTIVA
04/07INVENTIVA  : Corporate Presentation April 2021
PU
03/26INVENTIVA  : - Shareholders Meeting of April 16, 2021, Availability of the prepa..
AQ
03/25INVENTIVA S A  : Shareholders Meeting of April 16, 2021 – Availability of ..
PU
03/25INVENTIVA S A  : Combined Shareholders Meeting of April 16, 2021 - Availability ..
GL
03/24INVENTIVA S A  : Amendment to Annual Report by Foreign Issuer (SEC Filing - 20-F..
PU
03/16INVENTIVA S A  : Annual Report (SEC Filing - 20-F)
PU
03/15INVENTIVA S A  : announces filing of its 2020 Universal Registration Document an..
GL
03/08INVENTIVA S A  : Societe Generale Downgrades Inventiva to Sell Rating From Buy
MT
03/042020 FULL-YEAR RESULTS : Major advances in NASH and significantly extended cash ..
GL
03/04INVENTIVA S.A.  : Annual results
CO
More news
Financials
Sales 2021 2,10 M 2,52 M 2,52 M
Net income 2021 -51,4 M -61,6 M -61,6 M
Net cash 2021 71,8 M 86,0 M 86,0 M
P/E ratio 2021 -7,81x
Yield 2021 -
Capitalization 436 M 523 M 523 M
EV / Sales 2021 174x
EV / Sales 2022 216x
Nbr of Employees 91
Free-Float 73,7%
Chart INVENTIVA
Duration : Period :
Inventiva Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INVENTIVA
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 26,38 €
Last Close Price 11,30 €
Spread / Highest target 307%
Spread / Average Target 133%
Spread / Lowest Target -17,7%
EPS Revisions
Managers and Directors
NameTitle
Frédéric Cren Chairman & Chief Executive Officer
Jean Volatier Chief Financial & Administrative Officer
Pierre Broqua Director, Deputy CEO & Chief Scientific Officer
Michael P. Cooreman Chief Medical Officer
Chris Buyse Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
INVENTIVA-3.58%523
GILEAD SCIENCES, INC.12.89%84 193
VERTEX PHARMACEUTICALS INCORPORATED-7.17%56 783
REGENERON PHARMACEUTICALS, INC.2.39%52 343
WUXI APPTEC CO., LTD.-0.05%50 466
BIONTECH SE85.89%36 600